Replies to post #196506 on Biotech Values

[justrpaul]

ESRX CC -

Did their promise to open up access to all HCV patients regardless of disease stage come up in the Q and A?

[DewDiligence]

ABBV echoed ESRX wrt the revised V-Pak FDA label:

Answer2 final question on $ABBV CC re-iterated: revised FDA label4 V-Pak not material change wrt sales. (Echoes what $ESRX said on its CC.)

— Roy Friedman (@DewDiligence) October 30, 2015